Current News

Academic members in the former DRIVE-AB project has completed a policyletter that suggests a new mechanism to stimulate both innovation and access to antibiotics on a European level. This mechanism is built upon the Swedish politmodel and includes generic antibiotics.

Since Uppsala University is mitigating from the editing program InfoGlue to Sitevision for it's webpages, Platinea will also mitigate and thereby update our webpage. Deadline for the mitigation is during spring 2024.

Platinea will still have the same webpage adress. But keep an eye out for the update of the page!

On the 19th of October, PLATINEA hosted the yearly fall-workshop. This workshop's theme was: Focus Scandinavia.

The Public Health Agency of Sweden receives a government assignment to conduct a prestudy about a new compensation model for security stocks of generic antibiotics.

The workshop kicked-off with Thomas and Enrico welcoming all 40 participants!

PLATINEA will participate at EU: s high-level meeting on the question of antimicrobial resistance, which takes place in Stockholm on Monday the 6^th of march.

HERA, the European Health Emergency Preparedness and Response Authority has recently published two reports about stockpiling as a solution to increase availability of antibiotics in the EU. 

At the General Assembly on the 14th of October this year, three new partners were voted to be a part of Platinea. We are happy to welcome Karo Pharma, Cortexa Life Science and Region Västerbotten to the collaboration platform Platinea! Platinea now consists of 21 partners.

Unnecessary or incorrect use of antibiotics leads to a greater risk of developing resistance and reduced ability to treat infections. The development of new antibiotics is slow, which makes it important to improve access to and use of existing preparations. Many antibiotics that are widely used today were approved at a time when the requirements for documentation were lower.

Covid-19 investments can become a model - A European fund to stimulate antibiotic research according to the corona model. It was one of many proposals discussed at a seminar on Tuesday.

In a short time, the healthcare system and society have been quickly transformed to face the threat from the new coronavirus. International collaborations have been established, new supply chains have been established and new payment models for medicines and vaccines have been developed. How can these experiences contribute to increasing the availability of antibiotics in Sweden - in the short and long term?

We have the pleasure to announce that Pfizer joined PLATINEA as a part May 20, 2020. We look forward to collaborate with our new part.

-Enrico Baraldi, Project manager, PLATINEA

The Public Health Agency of Sweden, in collaboration with PLATINEA, has inventoried the knowledge gaps and needs for scientific studies that exist in the area of antibiotic use.

An integrated, AI-based data system was one of the measures against the problem of antibiotic shortages in Sweden that was discussed at a breakfast meeting on March 10, 2020.

PLATINEA has mapped why there is a shortage of antibiotics in healthcare.

Antibiotics have revolutionized modern medicine and are often lifesaving, if available. In 2019, 59 antibiotics were listed as backlogged, eight of which were oral suspensions. At the time of this article, 17 antibiotics were backlisted.

Immediately introduce a national safety stock of inpatient antibiotics. This is the message of a new report.

The shortage of antibiotics is so worrying that national stockpiles should be introduced immediately, according to a new report.